Stories about: Sigma
- +
Intelliheart tests in Amcal pharmacies 13/06/2008 12:08:09
IM Medical to sell Intelliheart tests through Amcal pharmacies - +
How the Bindeez were busted 25/01/2008 12:32:00
Biochemical geneticist Kevin Carpenter discusses how he helped tracked down the blip in the Bindeez beads. - +
Stocker rejoins CSIRO 02/07/2007 10:54:56
Former CSIRO chief John Stocker is now chairman of the board. - +
DNA-directed RNAi and the crown jewels 16/05/2007 10:55:31
When Merck announced last year it was buying Sirna Therapeutics for over US$1 billion, the world sat up and took notice. RNAi was now being seen as not only a revolution in our understanding but something with an unimaginable dollar value as well. - +
Reshaped Australian healthcare firms hold promise 06/02/2006 08:16:40
Most of Australia's leading healthcare firms are expected to post strong first-half profit growth and provide positive outlook statements as the benefits of takeovers and spin-offs start to filter through, according to analysts. - +
Benitec tells AGM of better times ahead 30/11/2005 14:27:48
"Seeing you all here means the company has survived," the chairman of RNAi specialist Benitec (ASX:BLT) Ray Whitten, told shareholders at today's AGM in Sydney. - +
CSIRO, Benitec strengthen RNAi patent positions 24/10/2005 15:04:24
The legal mists are lifting from Black Mountain in Canberra, and Mountain View in California, clarifying the ownership of key patents on RNA interference (RNAi) gene silencing technology. - +
Local pharma firms to distribute Funhaler 21/09/2005 12:32:15
Perth-based biomedical devices developer Visiomed Group (ASX:VSG) has successfully competed negotiations with three pharmaceutical wholesale distributors in Australia for the distribution of its Funhaler incentive asthma spacer into Australian pharmacies. - +
NeuroSolutions appoints Sigma Aldrich for scale-up 26/08/2005 14:47:19
NeuroSolutions, the UK based subsidiary of newly listed neurology-focused biotech company NeuroDiscovery (ASX:NDL) has identified and selected Sigma Aldrich to provide scale-up and manufacturing services in relation to its lead pain drug candidate, NSL-043, which is due to enter a phase I clinical trial later this year. - +
GroPep reports double profits 22/08/2005 14:27:59
Adelaide-based GroPep (ASX:GRO) has recorded pre-tax profit of AUD$3.1 million for the year ending 30 June 2005, an increase of more than 200 per cent over the $1 million reported last year. - +
Fluorotechnics secures deal with Sigma Aldrich 05/07/2005 14:48:29
Macquarie University spinoff Fluorotechnics is establishing a reputation for lucrative liaisons with giants, announcing a global marketing agreement with Sigma Aldrich for its new-tech FluoroProfile protein-quantification kits.
Additional Resources
Newsletter Subscription
Australian Life Scientist Member Login
Kingston Technology Launches HyperX T1 Series Memory 2008-11-19 11:00:00+11
Erase your discs with Lite-On SmartErase 2008-11-12 14:00:00+11
Antarctica NZ to Optimise Satellite Communications over the WAN with Expand Networks 2008-11-11 08:22:00+11
Kingston Technology Launches HyperX DDR3 2GHz Triple-Channel Memory in Support of Intel Core i7, X58 Platforms 2008-11-06 16:40:00+11
WD TV™ HD Media Player brings Digital Media Collections to the Big Screen 2008-11-05 11:00:00+11
Sponsored Links


